Shandong Bailong Chuangyuan Bio-Tech Co., Ltd. (SHA:605016)

SHA:605016 Revenue

Shandong Bailong Chuangyuan Bio-Tech had revenue of 366.85M CNY in the quarter ending June 30, 2026, with 9.22% growth. This brings the company's total for the last twelve months to 1.49B, up 17.32% year-over-year. In the year 2025, Shandong Bailong Chuangyuan Bio-Tech had annual revenue of 1.38B with 19.75% growth. That makes Shandong Bailong Chuangyuan Bio-Tech the 16,654th largest company in the world by revenue and 3,018th in China.

• Revenue (ttm): 1.49B
• Revenue Growth: +17.32%
• P/S Ratio: 4.96
• Revenue / Employee: 1.50M
• Employees: 990
• Market Cap: 7.43B

Revenue Chart

Chart

Chart

Revenue by Segment

By Segment

Chart

• Dietary Fiber Series 756.57M 56.3%
• Prebiotics Series 392.84M 29.2%
• Healthy Sweetener Series 194.28M 14.4%
• Other Starch Sugar (Alcohol) 1.04M 0.1%

By Geography

Chart

• Overseas 923.40M 68.7%
• East China 210.33M 15.6%
• Central China 88.38M 6.6%
• Southern China 42.80M 3.2%
• Northwestern China 29.74M 2.2%
• North China 25.73M 1.9%
• Northeast China 19.25M 1.4%
• Southwest China 5.08M 0.4%

Fiscal year ended Dec 31, 2025 See the full SHA:605016 breakdown

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	1.38B	227.40M	19.75%
Dec 31, 2024	1.15B	283.39M	32.64%
Dec 31, 2023	868.26M	146.37M	20.28%
Dec 31, 2022	721.89M	68.54M	10.49%
Dec 31, 2021	653.36M	153.73M	30.77%

Data Source: S&P Global Market Intelligence Last updated: Aug 30, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Oct 27, 2026

Data Sources Report a data error